FAAHP1

Across TCGA pan-cancer cohorts, FAAHP1 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of FAAHP1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where FAAHP1 RNA is repressed in tumor relative to normal tissue. In most cancer types FAAHP1 is over-expressed in tumor, although a few such as THCA and LUSC show the opposite, repressed pattern.

THCA, BLCA, and LIHC are the cancer types where FAAHP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FAAHP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	II,III,IV	−0.995	<.001	9	view →
BLCA	All	All	+0.493	<.001	7	view →
LIHC	All	All	+0.163	<.001	4	view →
CHOL	All	All	+0.511	.003	2	view →
KIRC	All	All	+0.202	.002	2	view →
LUAD	Female	All	+0.254	.028	1	view →
LUSC	All	II,III,IV	−0.201	.040	1	view →
STAD	All	All	+0.132	.017	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

FAAHP1–THCA

Open the THCA breakdown →